| Title |
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, January 2009
|
| DOI | 10.1007/s10549-009-0310-8 |
| Pubmed ID | |
| Authors |
Xiaolei Zhou, David Cella, David Cameron, Mayur M. Amonkar, Anthony Segreti, Steven Stein, Mel Walker, Charles E. Geyer |
Mendeley readers
The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 3 | 3% |
| United Kingdom | 2 | 2% |
| Spain | 1 | 1% |
| Unknown | 80 | 93% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 18 | 21% |
| Student > Master | 9 | 10% |
| Student > Bachelor | 9 | 10% |
| Other | 8 | 9% |
| Student > Ph. D. Student | 6 | 7% |
| Other | 16 | 19% |
| Unknown | 20 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 31% |
| Psychology | 6 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
| Economics, Econometrics and Finance | 5 | 6% |
| Agricultural and Biological Sciences | 5 | 6% |
| Other | 14 | 16% |
| Unknown | 23 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2018.
All research outputs
#7,474,859
of 22,851,489 outputs
Outputs from Breast Cancer Research and Treatment
#1,656
of 4,659 outputs
Outputs of similar age
#49,550
of 170,619 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#16
of 31 outputs
Altmetric has tracked 22,851,489 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,659 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one is in the 41st percentile – i.e., 41% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,619 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.